OBJECTIVES: We examined the association between mood symptoms and 10-year CVD risk estimated by Framingham risk score in a cohort of patients with bipolar disorder. METHODS: Veterans with bipolar disorder and CVD risk factors (N=118) were recruited from outpatient VA clinics. CVD risk factor data were collected from electronic medical records and patient surveys, and used to calculate patient Framingham Scores. The relationship between mood symptoms (depressive, manic) and Framingham scores was examined, as was the relationship between mental health symptoms and individual CVD risk factors (lipids, blood pressure, weight, smoking, and fasting glucose). RESULTS: Mean sample age was 53 years (SD=9.9), 17% were female, and 5% were African-American. Almost 70% were obese (BMI≥30), 84% had hyperlipidemia, 70% were hypertensive, and 25% had diabetes. Nineteen percent had a Framingham score of >20%, indicative of elevated 10-year risk of developing CVD. After adjusting for age, gender, diabetes diagnosis, smoking status, and mood symptoms, patients with clinically significant depressive symptoms had a 6-fold increased odds of having a Framingham score of >20% (OR=6.1, p=0.03) while clinically significant manic symptoms were not associated with the Framingham score (OR=0.6, p=0.36). Depressive symptoms were also associated with elevated BMI, fasting glucose, and blood pressure. LIMITATIONS: Single-site study reliant on cross-sectional and self-reported mood measures. CONCLUSION: After controlling for physiologic correlates, depressive symptoms were associated with greater relative 10-year risk for CVD mortality among patients with bipolar disorder. Interventions that address self-management of depressive symptoms may help persons with bipolar disorder decrease CVD risk. Published by Elsevier B.V.
OBJECTIVES: We examined the association between mood symptoms and 10-year CVD risk estimated by Framingham risk score in a cohort of patients with bipolar disorder. METHODS: Veterans with bipolar disorder and CVD risk factors (N=118) were recruited from outpatient VA clinics. CVD risk factor data were collected from electronic medical records and patient surveys, and used to calculate patient Framingham Scores. The relationship between mood symptoms (depressive, manic) and Framingham scores was examined, as was the relationship between mental health symptoms and individual CVD risk factors (lipids, blood pressure, weight, smoking, and fasting glucose). RESULTS: Mean sample age was 53 years (SD=9.9), 17% were female, and 5% were African-American. Almost 70% were obese (BMI≥30), 84% had hyperlipidemia, 70% were hypertensive, and 25% had diabetes. Nineteen percent had a Framingham score of >20%, indicative of elevated 10-year risk of developing CVD. After adjusting for age, gender, diabetes diagnosis, smoking status, and mood symptoms, patients with clinically significant depressive symptoms had a 6-fold increased odds of having a Framingham score of >20% (OR=6.1, p=0.03) while clinically significant manic symptoms were not associated with the Framingham score (OR=0.6, p=0.36). Depressive symptoms were also associated with elevated BMI, fasting glucose, and blood pressure. LIMITATIONS: Single-site study reliant on cross-sectional and self-reported mood measures. CONCLUSION: After controlling for physiologic correlates, depressive symptoms were associated with greater relative 10-year risk for CVD mortality among patients with bipolar disorder. Interventions that address self-management of depressive symptoms may help persons with bipolar disorder decrease CVD risk. Published by Elsevier B.V.
Authors: David E Goodrich; Amy M Kilbourne; Zongshan Lai; Edward P Post; Nicholas W Bowersox; Briana Mezuk; Karen Schumacher; Margretta Bramlet; Deborah E Welsh; Mark S Bauer Journal: Contemp Clin Trials Date: 2012-02-23 Impact factor: 2.226
Authors: Christine M Ramsey; Jeannie-Marie Leoutsakos; Lawrence S Mayer; William W Eaton; Hochang B Lee Journal: J Affect Disord Date: 2010-06-08 Impact factor: 4.839
Authors: Paul A Heidenreich; Justin G Trogdon; Olga A Khavjou; Javed Butler; Kathleen Dracup; Michael D Ezekowitz; Eric Andrew Finkelstein; Yuling Hong; S Claiborne Johnston; Amit Khera; Donald M Lloyd-Jones; Sue A Nelson; Graham Nichol; Diane Orenstein; Peter W F Wilson; Y Joseph Woo Journal: Circulation Date: 2011-01-24 Impact factor: 29.690
Authors: Amy M Kilbourne; Brian E Perron; Briana Mezuk; Deborah Welsh; Mark Ilgen; Mark S Bauer Journal: Psychosom Med Date: 2009-08-06 Impact factor: 4.312
Authors: Amy M Kilbourne; Cheryl Irmiter; Jeff Capobianco; Kathleen Reynolds; Karen Milner; Kristen Barry; Frederic C Blow Journal: Adm Policy Ment Health Date: 2008-05-28
Authors: M L Prieto; A B Cuéllar-Barboza; W V Bobo; V L Roger; F Bellivier; M Leboyer; C P West; M A Frye Journal: Acta Psychiatr Scand Date: 2014-05-22 Impact factor: 6.392
Authors: Quintí Foguet-Boreu; Maria Isabel Fernandez San Martin; Gemma Flores Mateo; Edurne Zabaleta Del Olmo; Luís Ayerbe García-Morzon; Maria Perez-Piñar López; Luis Miguel Martin-López; Javier Montes Hidalgo; Concepción Violán Journal: BMC Psychiatry Date: 2016-05-12 Impact factor: 3.630
Authors: Danielle F Loeb; Samantha Pelican Monson; Steven Lockhart; Cori Depue; Evette Ludman; Donald E Nease; Ingrid A Binswanger; Danielle M Kline; Frank V de Gruy; Dixie G Good; Elizabeth A Bayliss Journal: BMC Psychiatry Date: 2019-10-15 Impact factor: 3.630
Authors: Pamela Ouyang; Nanette K Wenger; Doris Taylor; Janet W Rich-Edwards; Meir Steiner; Leslee J Shaw; Sarah L Berga; Virginia M Miller; Noel Bairey Merz Journal: Biol Sex Differ Date: 2016-03-31 Impact factor: 5.027
Authors: Danielle F Loeb; Danielle M Kline; Kurt Kroenke; Cynthia Boyd; Elizabeth A Bayliss; Evette Ludman; L Miriam Dickinson; Ingrid A Binswanger; Samantha P Monson Journal: BMC Fam Pract Date: 2019-09-06 Impact factor: 2.497